Table 1. Anthropometric and physiologic characteristics of control group (CG), athletes with normal heart dimension (LVN), and athletes with heart hypertrophy (LVH). Data are means(±SD).
| VARIABLE |
CG (n = 14) |
LVN ( n = 15) |
LVH (n = 15) |
| Age [yr] |
20.9 (.9) |
21.8 (2.2) |
22.5 (1.3) |
| Height [m] |
1.77 (.05) |
177.1 (4.9) |
179.7 (5.7) |
| Body mass [kg] |
72.6 (6.6) |
69.7 (5.3) |
71.0 (5.3) |
| BMI [kg·m-2] |
23.1 (2.6) |
22.9 (1.5) |
22.0 (1.1) |
| FAT [%] |
13.9 (3.6) |
11.4 (4.2) † |
6.8 (1.9) ** ## |
| TBW [kg] |
45.7 (1.1) |
46.4 (4.8) |
48.0 (3.3) |
| Hct R[%] |
46.1 (3.2) |
45.2 (2.3) |
46.3 (2.8) |
| Hct MAX [%] |
49.6 (3.5) |
48.8 (2.5) |
48.2 (2.4) |
| VO2max [ml·min-1·kg-1] |
50.3 (3.3) |
63.0 (11.0) ## |
70.3 (6.1) ***# |
| LApeak [mmol/l] |
9.9 (1.3) |
9.8 (1.1) |
9.9 (1.2) |
| Hct [%] |
46.1 (3.2) |
45.2 (2.3) |
46.3 (2.8) |
| Wmax [W] |
289 (17) |
357 (52) † † |
413 (19.2) ***## |
LA = peak blood lactate concentration;,W = power output at maximal intensity of exercise in control group (CG), athleteswith normal heart dimension (LVN ), and athletes with heart hypertrophy (LVH). *** p < 0.001 LVH CG; # p < 0.05LVH . LVN; ## p < 0.01 LVH . LVN; † p < 0.05 CG . LVN; † † p < 0.01 CG . LVN
